HomeAboutRankingsData Sources
Β© 2026 GeneE
🧬
GeneE
10 sources retrieved Β· Most recent: April 2026 Β· Index updated 14 days ago
β“˜GeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
PRPH2
peripherin 2
Chromosome 6 Β· 6p21.1
NCBI Gene: 5961Ensembl: ENSG00000112619.8HGNC: HGNC:9942UniProt: P23942
121PubMed Papers
25Diseases
0Drugs
360Pathogenic Variants
RESEARCH IMPACT
Variant-Rich
CLINICAL
OMIM Disease Gene
DATA QUALITY
βœ“ Experimental GO Evidenceβœ“ Swiss-Prot Reviewed
protein bindingprotein localization to plasma membraneprotein maturationplasma membraneretinitis pigmentosapatterned macular dystrophy 1vitelliform macular dystrophy 3choroidal dystrophy, central areolar 2
✦AI Summary

PRPH2 encodes peripherin-2, a photoreceptor-specific tetraspanin protein essential for rod and cone outer segment formation and maintenance 1. The protein is critical for retinal outer segment disk morphogenesis and organization of photoreceptor inner segments, with roles in maintaining outer nuclear layer thickness 2. PRPH2 mutations cause diverse inherited retinal diseases, with over 90 disease-causing variants identified 1. These mutations are associated with multiple phenotypes including retinitis pigmentosa, pattern dystrophy, macular dystrophies, and central areolar choroidal dystrophy 342. In a large UK cohort, PRPH2 variants contributed to disease in a substantial proportion of inherited retinal disease families, associating with both dominant and recessive phenotypes 3. Mouse models carrying the p.Arg195Leu mutation demonstrate progressive retinal degeneration with reduced visual function, altered outer segment structure, and synaptic remodeling with microglial activation, recapitulating human disease 5. Pathogenic mechanisms involve haploinsufficiency and protein misfolding, complicating therapeutic development 1. Gene therapy approaches using adeno-associated viruses have shown promise in animal models but face challenges due to the critical requirement for precise peripherin-2 dosage 1.

Sources cited
1
PRPH2 encodes peripherin-2, a photoreceptor-specific tetraspanin critical for rod and cone outer segment formation and maintenance; over 90 disease-causing mutations identified; gene therapy approaches and haploinsufficiency challenges
PMID: 25167981
2
PRPH2 variants associated with range of dominant and recessive inherited retinal disease phenotypes; among most common IRD genes in large UK cohort
PMID: 38219857
3
PRPH2 mutations account for significant proportion of macular and cone/cone-rod dystrophy cases; mutations identified in disease patients
PMID: 29555955
4
PRPH2 associated with pattern dystrophy and cone/cone-rod dystrophies as examples of inherited retinal diseases with heterogeneous phenotypes
PMID: 38278208
5
Prph2 knock-in mouse model with p.Arg195Leu mutation shows progressive retinal degeneration, altered outer segment structure, synaptic remodeling, and microglial activation; recapitulates human central areolar choroidal dystrophy
PMID: 37914688
Disease Associationsβ“˜25
retinitis pigmentosaOpen Targets
0.82Strong
patterned macular dystrophy 1Open Targets
0.76Strong
vitelliform macular dystrophy 3Open Targets
0.75Strong
choroidal dystrophy, central areolar 2Open Targets
0.72Strong
Butterfly-shaped pigment dystrophyOpen Targets
0.72Strong
retinopathyOpen Targets
0.68Moderate
Cone rod dystrophyOpen Targets
0.63Moderate
cone-rod dystrophyOpen Targets
0.62Moderate
macular degenerationOpen Targets
0.60Moderate
Macular dystrophyOpen Targets
0.60Moderate
adult-onset foveomacular vitelliform dystrophyOpen Targets
0.58Moderate
Retinal dystrophyOpen Targets
0.58Moderate
Stargardt diseaseOpen Targets
0.57Moderate
fundus albipunctatusOpen Targets
0.55Moderate
patterned dystrophy of the retinal pigment epitheliumOpen Targets
0.54Moderate
vitelliform macular dystrophy 2Open Targets
0.54Moderate
multifocal pattern dystrophy simulating fundus flavimaculatusOpen Targets
0.52Moderate
retinitis punctata albescensOpen Targets
0.50Moderate
age-related macular degenerationOpen Targets
0.50Moderate
central areolar choroidal dystrophyOpen Targets
0.50Moderate
Choroidal dystrophy, central areolar 2UniProt
Macular dystrophy, patterned, 1UniProt
Macular dystrophy, vitelliform, 3UniProt
Retinitis pigmentosa 7UniProt
Retinitis punctata albescensUniProt
Pathogenic Variants360
NM_000322.5(PRPH2):c.828+3A>TPathogenic
not provided|PRPH2-related disorder|Retinal dystrophy|Patterned dystrophy of the retinal pigment epithelium|Vitelliform macular dystrophy 2|Choroideremia|Cone-rod dystrophy|Retinitis pigmentosa|Doyne honeycomb retinal dystrophy|Stargardt disease|Patterned macular dystrophy 1
β˜…β˜…β˜†β˜†2026
NM_000322.5(PRPH2):c.581+1G>APathogenic
Retinal dystrophy|not provided|PRPH2-related disorder
β˜…β˜…β˜†β˜†2026
NM_000322.5(PRPH2):c.163del (p.Ser55fs)Pathogenic
Stargardt disease|not provided|PRPH2-related disorder
β˜…β˜…β˜†β˜†2026β†’ Residue 55
NM_000322.5(PRPH2):c.499G>A (p.Gly167Ser)Pathogenic
Retinitis pigmentosa|not provided|PRPH2-related disorder|Retinal dystrophy|Stargardt disease
β˜…β˜…β˜†β˜†2026β†’ Residue 167
NM_000322.5(PRPH2):c.628C>T (p.Pro210Ser)Pathogenic
not provided|Vitelliform macular dystrophy 2|PRPH2-related disorder
β˜…β˜…β˜†β˜†2026β†’ Residue 210
NM_000322.5(PRPH2):c.646_649delinsGG (p.Pro216fs)Pathogenic
PRPH2-related disorder|Retinitis pigmentosa|not provided|Retinal dystrophy
β˜…β˜…β˜†β˜†2026β†’ Residue 216
NM_000322.5(PRPH2):c.500G>A (p.Gly167Asp)Pathogenic
Patterned macular dystrophy 1|not provided|PRPH2-related disorder|Choroidal dystrophy, central areolar 2
β˜…β˜…β˜†β˜†2026β†’ Residue 167
NM_000322.5(PRPH2):c.422A>G (p.Tyr141Cys)Pathogenic
not provided|Patterned macular dystrophy 1|PRPH2-related disorder|Retinal dystrophy|Patterned dystrophy of the retinal pigment epithelium|Stargardt disease|Cone-rod dystrophy|Autosomal recessive bestrophinopathy|Retinitis pigmentosa|Vitelliform macular dystrophy 3|Retinitis pigmentosa 7;Pigmentary retinal dystrophy;Patterned macular dystrophy 1;Choroidal dystrophy, central areolar 2;Vitelliform macular dystrophy 3
β˜…β˜…β˜†β˜†2026β†’ Residue 141
NM_000322.5(PRPH2):c.659G>A (p.Arg220Gln)Pathogenic
not provided|Retinitis pigmentosa|Retinal dystrophy|PRPH2-related disorder|Macular dystrophy|Retinal disorder
β˜…β˜…β˜†β˜†2026β†’ Residue 220
NM_000322.5(PRPH2):c.424C>T (p.Arg142Trp)Pathogenic
Choroidal dystrophy, central areolar 2|not provided|Cone dystrophy|Progressive cone dystrophy (without rod involvement)|maculopathy|Retinal dystrophy|PRPH2-related disorder|Stargardt disease|Retinitis pigmentosa|Patterned dystrophy of the retinal pigment epithelium|Patterned macular dystrophy 1
β˜…β˜…β˜†β˜†2026β†’ Residue 142
NM_000322.5(PRPH2):c.513dup (p.Arg172fs)Pathogenic
not provided|PRPH2-related disorder|Vitelliform macular dystrophy 3
β˜…β˜…β˜†β˜†2026β†’ Residue 172
NM_000322.5(PRPH2):c.605G>A (p.Gly202Glu)Pathogenic
PRPH2-related disorder|Patterned macular dystrophy 1
β˜…β˜…β˜†β˜†2025β†’ Residue 202
NM_000322.5(PRPH2):c.629C>G (p.Pro210Arg)Pathogenic
not provided|PRPH2-related disorder|Retinal dystrophy|Stargardt disease|Patterned dystrophy of the retinal pigment epithelium|Vitelliform macular dystrophy 2|Vitelliform macular dystrophy 3
β˜…β˜…β˜†β˜†2025β†’ Residue 210
NM_000322.5(PRPH2):c.638G>A (p.Cys213Tyr)Pathogenic
not provided|PRPH2-related disorder|Retinal dystrophy|Patterned macular dystrophy 1|Stargardt disease|Retinal disorder
β˜…β˜…β˜†β˜†2025β†’ Residue 213
NM_000322.5(PRPH2):c.715C>T (p.Gln239Ter)Pathogenic
not provided|Macular dystrophy|Patterned dystrophy of the retinal pigment epithelium|PRPH2-related disorder|Stargardt disease|Choroidal dystrophy, central areolar 2|Retinal dystrophy
β˜…β˜…β˜†β˜†2025β†’ Residue 239
NM_000322.5(PRPH2):c.554T>C (p.Leu185Pro)Pathogenic
Retinitis pigmentosa 7, digenic|not provided|Leber congenital amaurosis 18|Patterned macular dystrophy 1|Retinal dystrophy|Patterned dystrophy of the retinal pigment epithelium|PRPH2-related disorder|Retinitis pigmentosa
β˜…β˜…β˜†β˜†2025β†’ Residue 185
NM_000322.5(PRPH2):c.761T>A (p.Leu254Gln)Pathogenic
Patterned dystrophy of the retinal pigment epithelium|Retinitis pigmentosa|not provided|PRPH2-related disorder
β˜…β˜…β˜†β˜†2025β†’ Residue 254
NM_000322.5(PRPH2):c.647C>T (p.Pro216Leu)Pathogenic
Retinitis pigmentosa 7|not provided|Retinitis pigmentosa|PRPH2-related disorder|Patterned dystrophy of the retinal pigment epithelium|Retinal dystrophy
β˜…β˜…β˜†β˜†2025β†’ Residue 216
NM_000322.5(PRPH2):c.537G>T (p.Trp179Cys)Pathogenic
Retinal dystrophy|PRPH2-related disorder|Patterned dystrophy of the retinal pigment epithelium|not provided
β˜…β˜…β˜†β˜†2025β†’ Residue 179
NM_000322.5(PRPH2):c.410G>A (p.Gly137Asp)Pathogenic
Retinitis pigmentosa|Retinal dystrophy|PRPH2-related disorder|not provided|Retinitis pigmentosa 7
β˜…β˜…β˜†β˜†2025β†’ Residue 137
View on ClinVar β†—
Related Genes
RHOProtein interaction94%AIPL1Protein interaction93%IMPG1Protein interaction88%RPE65Protein interaction88%EYSProtein interaction86%PCAREProtein interaction84%
Tissue Expression6 tissues
Ovary
100%
Brain
74%
Lung
35%
Heart
31%
Liver
7%
Bone Marrow
0%
Gene Interaction Network
Click a node to explore
PRPH2RHOAIPL1IMPG1RPE65EYSPCARE
PROTEIN STRUCTURE
Preparing viewer…
PDB7ZW1 Β· 3.70 Γ… Β· EM
View on RCSB β†—
Constraintβ“˜
LOEUFβ“˜
0.77LoF Tolerant
pLIβ“˜
0.01Tolerant
Observed/Expected LoF0.52 [0.35–0.77]
RankingsWhere PRPH2 stands among ~20K protein-coding genes
  • #3,894of 20,598
    Most Researched121 Β· top quartile
  • #159of 5,498
    Most Pathogenic Variants360 Β· top 5%
  • #6,269of 17,882
    Most Constrained (LOEUF)0.77
Genes detectedPRPH2
Sources retrieved10 papers
Response timeβ€”
πŸ“„ Sources
10β–Ό
1
Spectrum of Genetic Variants in the Most Common Genes Causing Inherited Retinal Disease in a Large Molecularly Characterized United Kingdom Cohort.
PMID: 38219857
Ophthalmol Retina Β· 2024
1.00
2
PMID: 20301590
0.90
3
Clinical and genetic characteristics of 251 consecutive patients with macular and cone/cone-rod dystrophy.
PMID: 29555955
Sci Rep Β· 2018
0.80
4
Phenotyping and genotyping inherited retinal diseases: Molecular genetics, clinical and imaging features, and therapeutics of macular dystrophies, cone and cone-rod dystrophies, rod-cone dystrophies, Leber congenital amaurosis, and cone dysfunction syndromes.
PMID: 38278208
Prog Retin Eye Res Β· 2024
0.70
5
Gene therapy for PRPH2-associated ocular disease: challenges and prospects.
PMID: 25167981
Cold Spring Harb Perspect Med Β· 2014
0.60